IV iron dextran was the most cost-effective treatment, yielding 19.26 quality-adjusted life years at a cost of $157,500 vs 19.10 costing $152,900 for oral ferrous sulfate. HealthDay News — Intravenous ...
China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that, the Group through its wholly-owned subsidiary entered into an exclusive commercialization and supply agreement ...
For a monthly blood loss of 420 mL, the cost was $174,400 with IV iron dextran compared with $157,000 with oral ferrous sulfate, and the effectiveness was 18.91 and 17.19, respectively. The use of ...
First and only high-dose intravenous iron for iron deficiency anemia of various etiologies SHIRLEY, N.Y.--(BUSINESS WIRE)--American Regent, Inc., a subsidiary of Luitpold Pharmaceuticals, Inc. (a ...
IV iron dextran is most cost-effective, yielding 19.26 QALYs compared with 19.10 QALYs for oral ferrous sulfate. (HealthDay News) — Intravenous (IV) iron dextran is the most cost-effective strategy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results